Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GLSI Greenwich Lifesciences Inc

未开盘 11-03 16:00:00 EST

15.92

-0.54

-3.28%

盘后16.25

+0.33+2.07%

19:53 EST

最高17.21	最低15.89	成交量6.64万
今开16.70	昨收16.46	日振幅8.02%
总市值2.34亿	流通市值1.22亿	总股本1,468万
成交额108.68万	换手率0.87%	流通股本765.31万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GLSI","market":"US","secType":"STK","nameCN":"Greenwich Lifesciences Inc","latestPrice":15.92,"timestamp":1793739600000,"preClose":16.46,"halted":0,"volume":66389,"hourTrading":{"tag":"盘后","latestPrice":16.25,"preClose":15.92,"latestTime":"19:53 EST","volume":1264,"amount":20508.85,"timestamp":1793753623028,"change":0.33,"changeRate":0.020729,"amplitude":0.020729},"delay":0,"changeRate":-0.03280680437424064,"floatShares":7653052,"shares":14678200,"eps":-1.578281,"marketStatus":"未开盘","change":-0.54,"latestTime":"11-03 16:00:00 EST","open":16.7,"high":17.21,"low":15.89,"amount":1086825.970897,"amplitude":0.080194,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.578281,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1793782800000},"marketStatusCode":0,"adr":0,"listingDate":1601006400000,"exchange":"NASDAQ","adjPreClose":16.46,"preHourTrading":{"tag":"盘前","latestPrice":17.41,"preClose":16.46,"latestTime":"06:46 EST","volume":100,"amount":1741,"timestamp":1793706415004,"change":0.95,"changeRate":0.057716,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":16.25,"preClose":15.92,"latestTime":"19:53 EST","volume":1264,"amount":20508.85,"timestamp":1793753623028,"change":0.33,"changeRate":0.020729,"amplitude":0.020729},"volumeRatio":0.430149},"requestUrl":"/m/hq/s/GLSI","defaultTab":"news","newsList":[{"id":"1117121694","title":"Greenwich Lifesciences：高管及IPO前投资者股份锁定期延长至2027年1月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=1117121694","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117121694?lang=zh_cn&edition=full","pubTime":"2026-08-10 18:09","pubTimestamp":1786356566,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences宣布，将其董事、高管以及IPO前投资者所持股份的锁定期延长至2027年1月31日。这一举措旨在进一步稳定公司股权结构，并强化市场对长期价值创造的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137171436","title":"Greenwich Lifesciences - Flamingo-01指导委员会支持扩大研究规模并加速患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1137171436","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137171436?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:08","pubTimestamp":1784542094,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences公司宣布，其Flamingo-01试验的指导委员会已正式批准增加研究规模，并全力推进患者招募加速进程。\n这一决定旨在更快地积累临床数据，为试验的后续推进提供更坚实的支持。加速入组有望缩短整体研究时间线。\n公司对指导委员会的支持表示欢迎，并认为此举将优化试验执行效率。市场密切关注该生物技术公司核心管线的进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175599511","title":"Greenwich Lifesciences 预计2026年第二季度现金消耗率为200万美元；截至2026年6月30日现金余额为890万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175599511","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175599511?lang=zh_cn&edition=full","pubTime":"2026-07-20 18:03","pubTimestamp":1784541793,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences Inc 公布了其2026年第二季度的财务预期。公司预计该季度的现金消耗率约为200万美元。与此同时，截至2026年6月30日，公司的现金及现金等价物余额为890万美元。这些数据反映了公司在特定时期的资金使用状况与财务流动性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170929019","title":"Greenwich Lifesciences宣布在欧洲获批使用商业化生产的Gp2用于Flamingo-01研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1170929019","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170929019?lang=zh_cn&edition=full","pubTime":"2026-07-09 18:05","pubTimestamp":1783591516,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences Inc宣布，其商业化生产的Gp2已获得在欧洲用于Flamingo-01研究的批准。这一进展标志着该公司在推进其核心候选产品方面取得了重要的监管里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100764518","title":"Greenwich Lifesciences 在2026年ASCO会议上公布Flamingo-01三期试验开放标签数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1100764518","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100764518?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:17","pubTimestamp":1780316234,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences 公司近期在2026年美国临床肿瘤学会年会上，公布了其关键性Flamingo-01三期临床试验的开放标签数据。这项研究成果的发布，标志着公司在肿瘤免疫治疗领域取得了新的进展，为后续的临床开发与监管申请提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129440133","title":"Greenwich Lifesciences Inc达成价值高达15.5亿美元现金交易，含首付款与里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1129440133","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129440133?lang=zh_cn&edition=full","pubTime":"2026-05-26 18:46","pubTimestamp":1779792373,"startTime":"0","endTime":"0","summary":"Greenwich Lifesciences Inc (GLSI) 宣布达成一项潜在价值最高可达15.5亿美元的现金交易协议。该交易结构包含首付款以及后续基于研发与商业化进展的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518209140","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大跌5.04%报11.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209140","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518209140?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:37","pubTimestamp":1741631846,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时37分，Greenwich Lifesciences, Inc.股票出现波动，股价快速下挫5.04%。截至发稿，该股报11.49美元/股，成交量9322股，换手率0.07%，振幅5.21%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311023726964071c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517535164","title":"Greenwich Lifesciences, Inc.盘中异动 快速下挫5.44%报11.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517535164","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517535164?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:49","pubTimestamp":1741272542,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时49分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下挫5.44%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224903abeb7cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516301329","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.29%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301329","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516301329?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:53","pubTimestamp":1740775997,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时53分，Greenwich Lifesciences, Inc.股票出现波动，股价急速上涨5.29%。截至发稿，该股报12.15美元/股，成交量1.4511万股，换手率0.11%，振幅4.85%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010453189896c7eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506306788","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.04%报13.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506306788?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:24","pubTimestamp":1737991477,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时24分，Greenwich Lifesciences, Inc.股票出现异动，股价急速上涨5.04%。截至发稿，该股报13.75美元/股，成交量1.1902万股，换手率0.09%，振幅4.20%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127232437abba6aed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505720299","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505720299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505720299?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:12","pubTimestamp":1737562326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时12分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨5.26%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123001207a22bc844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505191202","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505191202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505191202?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:03","pubTimestamp":1737482583,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时03分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅下挫5.28%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为2.22%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020303960bddc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503477583","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大跌7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503477583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503477583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778726,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Greenwich Lifesciences, Inc.股票出现波动，股价急速下跌7.11%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223206aba930af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223206aba930af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502847893","title":"Greenwich Lifesciences, Inc.盘中异动 大幅下挫6.14%报12.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502847893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502847893?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:19","pubTimestamp":1736522376,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时19分，Greenwich Lifesciences, Inc.股票出现异动，股价快速下挫6.14%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231936a21d1a16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110231936a21d1a16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501779750","title":"Greenwich Lifesciences, Inc.盘中异动 急速下跌5.14%报13.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501779750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501779750?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:20","pubTimestamp":1736349647,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日23时20分，Greenwich Lifesciences, Inc.股票出现异动，股价急速下跌5.14%。截至发稿，该股报13.10美元/股，成交量1.1805万股，换手率0.09%，振幅4.06%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108232047985f825f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108232047985f825f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501781596","title":"Greenwich Lifesciences, Inc.盘中异动 早盘股价大涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501781596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501781596?lang=zh_cn&edition=full","pubTime":"2025-01-08 00:09","pubTimestamp":1736266171,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日00时09分，Greenwich Lifesciences, Inc.股票出现波动，股价大幅上涨5.57%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108000931a218fd9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108000931a218fd9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500143436","title":"Greenwich Lifesciences, Inc.盘中异动 股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500143436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500143436?lang=zh_cn&edition=full","pubTime":"2025-01-03 23:53","pubTimestamp":1735919583,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日23时53分，Greenwich Lifesciences, Inc.股票出现波动，股价快速上涨5.71%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103235303985a4b7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103235303985a4b7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500223029","title":"Greenwich Lifesciences, Inc.盘中异动 大幅拉升8.49%报12.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500223029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500223029?lang=zh_cn&edition=full","pubTime":"2025-01-02 22:35","pubTimestamp":1735828529,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日22时35分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅上涨8.49%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223529a21301fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250102223529a21301fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GLSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500460476","title":"Greenwich Lifesciences, Inc.盘中异动 下午盘股价大涨5.13%报11.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500460476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2500460476?lang=zh_cn&edition=full","pubTime":"2025-01-01 02:41","pubTimestamp":1735670464,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日02时41分，Greenwich Lifesciences, Inc.股票出现异动，股价快速上涨5.13%。截至发稿，该股报11.47美元/股，成交量2.3914万股，换手率0.18%，振幅6.42%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010102410595f4605a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010102410595f4605a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2495775529","title":"Greenwich Lifesciences, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495775529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2495775529?lang=zh_cn&edition=full","pubTime":"2024-12-30 23:22","pubTimestamp":1735572142,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日23时22分，Greenwich Lifesciences, Inc.股票出现异动，股价大幅跳水5.22%。Greenwich Lifesciences, Inc.股票所在的生物技术行业中，整体跌幅为1.13%。Greenwich Lifesciences, Inc.公司简介：Greenwich lifessciences Inc 是一家临床阶段的生物制药公司，专注于开发 GP2，这是一种免疫疗法，用于预防已经接受过手术的患者乳腺癌复发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232222a20f3794&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230232222a20f3794&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.greenwichlifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0861},{"period":"1month","weight":-0.0624},{"period":"3month","weight":0.1063},{"period":"6month","weight":-0.326},{"period":"1year","weight":0.8885},{"period":"ytd","weight":-0.2423}],"compareEarnings":[{"period":"1week","weight":-0.0199},{"period":"1month","weight":-0.0199},{"period":"3month","weight":-0.0201},{"period":"6month","weight":0.0311},{"period":"1year","weight":0.1039},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Greenwich LifeSciences, Inc.成立于2006年8月29日，是特拉华州的一家公司。该公司是一家生物制药公司，正在开发GP2，这是一种旨在预防术后乳腺癌复发的免疫疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.082906},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00815},{"month":3,"riseRate":0.5,"avgChangeRate":0.044197},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.141916},{"month":5,"riseRate":0.5,"avgChangeRate":-0.011066},{"month":6,"riseRate":0.5,"avgChangeRate":0.028818},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.082858},{"month":8,"riseRate":0.666667,"avgChangeRate":0.034831},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.000127},{"month":10,"riseRate":0,"avgChangeRate":-0.081422},{"month":11,"riseRate":0.571429,"avgChangeRate":0.181202},{"month":12,"riseRate":0.5,"avgChangeRate":1.139783}],"exchange":"NASDAQ","name":"Greenwich Lifesciences Inc","nameEN":"Greenwich Lifesciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Greenwich Lifesciences Inc,GLSI,Greenwich Lifesciences Inc股票,Greenwich Lifesciences Inc股票老虎,Greenwich Lifesciences Inc股票老虎国际,Greenwich Lifesciences Inc行情,Greenwich Lifesciences Inc股票行情,Greenwich Lifesciences Inc股价,Greenwich Lifesciences Inc股市,Greenwich Lifesciences Inc股票价格,Greenwich Lifesciences Inc股票交易,Greenwich Lifesciences Inc股票购买,Greenwich Lifesciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Greenwich Lifesciences Inc(GLSI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Greenwich Lifesciences Inc(GLSI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}